NCT00455702View on ClinicalTrials.gov

Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Schizophrenia
Interventions
DRUG

d-cycloserine

50mg dose d-cycloserine v placebo

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00455702 - Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia | Biotech Hunter | Biotech Hunter